Sunitinib
- Generic name
- Sunitinib
- Strength / Form
- 12.5 mg Capsules
- Pack size
- 30 capsules
- Drug class
- Multi-targeted tyrosine kinase inhibitor (VEGFR / PDGFR / KIT / FLT3 / RET)
Approved for
Key Points
- Used in advanced renal cell carcinoma (kidney cancer)
- Used in GIST after imatinib resistance or intolerance
- Used in pancreatic neuroendocrine tumors
Prescription required. This medicine is supplied only against a valid prescription from your oncologist. Attach it to your order or send it on WhatsApp.
- Genuine sourcing
- Nationwide delivery
- Pay on delivery
About Sunitinib
Sunitinib is an oral multi-targeted tyrosine kinase inhibitor used to treat advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST) that no longer respond to imatinib, and pancreatic neuroendocrine tumors. It works by blocking signaling pathways that tumors use to grow new blood vessels and multiply.
Usage
Taken orally once daily, exactly as prescribed by your oncologist. Do not change the dose or stop treatment without medical guidance.
Always take this medicine exactly as prescribed by your oncologist. Do not start, stop or change the dose without medical advice.
Overview
Key Highlights
Details
Additional Information
Store below 25°C in a dry, cool place away from direct sunlight and out of reach of children.
Prescription required - dispensed only against a valid oncologist's prescription.
Blood pressure and blood counts should be monitored regularly during treatment.
Inform your doctor of any heart conditions, high blood pressure, or bleeding disorders before starting.
Not for use during pregnancy or breastfeeding unless directed by your doctor.
Check the batch number and expiry date on the packaging before use.
Support
Frequently Asked Questions
Sunitinib is used to treat advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST) that no longer respond to imatinib, and pancreatic neuroendocrine tumors.
It is a multi-targeted tyrosine kinase inhibitor that blocks signaling pathways tumors use to grow new blood vessels and multiply.
Taken orally, usually once daily, with or without food, following the cycle schedule set by your oncologist.
Common side effects include fatigue, diarrhea, high blood pressure, hand-foot skin reactions, and changes in blood counts. Report side effects to your doctor promptly.
Some medicines can interact with Sunitinib. Always tell your oncologist and pharmacist about every medicine and supplement you are taking.
Feedback
Customer Reviews
No reviews yet — be the first to share your experience.
Medical disclaimer: Information on this website is for general reference only and is not a substitute for professional medical advice. Oncology medicines must be used only under the supervision of a qualified oncologist and are supplied against a valid prescription.